63 related articles for article (PubMed ID: 21871888)
41. Inhibition of TGF-β signalling in combination with nal-IRI plus 5-Fluorouracil/Leucovorin suppresses invasion and prolongs survival in pancreatic tumour mouse models.
Hong E; Park S; Ooshima A; Hong CP; Park J; Heo JS; Lee S; An H; Kang JM; Park SH; Park JO; Kim SJ
Sci Rep; 2020 Feb; 10(1):2935. PubMed ID: 32076068
[TBL] [Abstract][Full Text] [Related]
42. The function of FAK/CCDC80/E-cadherin pathway in the regulation of B16F10 cell migration.
Pei G; Lan Y; Lu W; Ji L; Hua ZC
Oncol Lett; 2018 Oct; 16(4):4761-4767. PubMed ID: 30214608
[TBL] [Abstract][Full Text] [Related]
43. Identification of steroid-sensitive gene-1/Ccdc80 as a JAK2-binding protein.
O'Leary EE; Mazurkiewicz-Muñoz AM; Argetsinger LS; Maures TJ; Huynh HT; Carter-Su C
Mol Endocrinol; 2013 Apr; 27(4):619-34. PubMed ID: 23449887
[TBL] [Abstract][Full Text] [Related]
44. The role of AIB1 in breast cancer.
Chang AK; Wu H
Oncol Lett; 2012 Oct; 4(4):588-594. PubMed ID: 23226788
[TBL] [Abstract][Full Text] [Related]
45. Genes regulated in metastatic osteosarcoma: evaluation by microarray analysis in four human and two mouse cell line systems.
Muff R; Ram Kumar RM; Botter SM; Born W; Fuchs B
Sarcoma; 2012; 2012():937506. PubMed ID: 23213280
[TBL] [Abstract][Full Text] [Related]
46. Ccdc80-l1 Is involved in axon pathfinding of zebrafish motoneurons.
Brusegan C; Pistocchi A; Frassine A; Della Noce I; Schepis F; Cotelli F
PLoS One; 2012; 7(2):e31851. PubMed ID: 22384085
[TBL] [Abstract][Full Text] [Related]
47. Function of BCLAF1 in human disease.
Yu Z; Zhu J; Wang H; Li H; Jin X
Oncol Lett; 2022 Feb; 23(2):58. PubMed ID: 34992690
[TBL] [Abstract][Full Text] [Related]
48. Transcriptional repression of AIB1 by FoxG1 leads to apoptosis in breast cancer cells.
Li JV; Chien CD; Garee JP; Xu J; Wellstein A; Riegel AT
Mol Endocrinol; 2013 Jul; 27(7):1113-27. PubMed ID: 23660594
[TBL] [Abstract][Full Text] [Related]
49. AIB1 enhances estrogen-dependent induction of cyclin D1 expression.
Planas-Silva MD; Shang Y; Donaher JL; Brown M; Weinberg RA
Cancer Res; 2001 May; 61(10):3858-62. PubMed ID: 11358796
[TBL] [Abstract][Full Text] [Related]
50. A role for TGF-beta in estrogen and retinoid mediated regulation of the nuclear receptor coactivator AIB1 in MCF-7 breast cancer cells.
Lauritsen KJ; List HJ; Reiter R; Wellstein A; Riegel AT
Oncogene; 2002 Oct; 21(47):7147-55. PubMed ID: 12370804
[TBL] [Abstract][Full Text] [Related]
51. Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression.
Kushner MH; Ory V; Graham GT; Sharif GM; Kietzman WB; Thevissen S; Yuan M; Schmidt MO; Wellstein A; Riegel AT
EMBO Rep; 2020 Jan; 21(1):e48741. PubMed ID: 31788936
[TBL] [Abstract][Full Text] [Related]
52. ATBF1 inhibits estrogen receptor (ER) function by selectively competing with AIB1 for binding to the ER in ER-positive breast cancer cells.
Dong XY; Sun X; Guo P; Li Q; Sasahara M; Ishii Y; Dong JT
J Biol Chem; 2010 Oct; 285(43):32801-32809. PubMed ID: 20720010
[TBL] [Abstract][Full Text] [Related]
53. Transcriptional repression of the tumor suppressor DRO1 by AIB1.
Ferragud J; Avivar-Valderas A; Pla A; De Las Rivas J; Font de Mora J
FEBS Lett; 2011 Oct; 585(19):3041-6. PubMed ID: 21871888
[TBL] [Abstract][Full Text] [Related]
54. In search of a function for BCLAF1.
Sarras H; Alizadeh Azami S; McPherson JP
ScientificWorldJournal; 2010 Jul; 10():1450-61. PubMed ID: 20661537
[TBL] [Abstract][Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
